Canlyniadau Chwilio - Matthias Eder

Mireinio'r Canlyniadau
  1. 1
    Gene Silencing by Small Regulatory RNAs in Mammalian Cells

    Gene Silencing by Small Regulatory RNAs in Mammalian Cells gan Michaela Scherr, Matthias Eder

    Cyhoeddwyd 2007
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  2. 2
    [68Ga]Ga-PSMA-11: The First FDA-Approved 68Ga-Radiopharmaceutical for PET Imaging of Prostate Cancer

    [68Ga]Ga-PSMA-11: The First FDA-Approved 68Ga-Radiopharmaceutical for PET Imaging of Prostate Cancer gan Ute Hennrich, Matthias Eder

    Cyhoeddwyd 2021
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  3. 3
    [177Lu]Lu-PSMA-617 (PluvictoTM): The First FDA-Approved Radiotherapeutical for Treatment of Prostate Cancer

    [177Lu]Lu-PSMA-617 (PluvictoTM): The First FDA-Approved Radiotherapeutical for Treatment of Prostate Cancer gan Ute Hennrich, Matthias Eder

    Cyhoeddwyd 2022
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  4. 4
    Functional optical probing of the hippocampal trisynaptic circuit in vitro: network dynamics, filter properties, and polysynaptic induction of CA1 LTP

    Functional optical probing of the hippocampal trisynaptic circuit in vitro: network dynamics, filter properties, and polysynaptic induction of CA1 LTP gan Jens Stepan, Julien Dine, Matthias Eder

    Cyhoeddwyd 2015
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  5. 5
    Dual-Labeled Small Peptides in Cancer Imaging and Fluorescence-Guided Surgery: Progress and Future Perspectives

    Dual-Labeled Small Peptides in Cancer Imaging and Fluorescence-Guided Surgery: Progress and Future Perspectives gan Patrick G. Minges, Matthias Eder, Ann-Christin Eder

    Cyhoeddwyd 2025
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  6. 6
    PSMA as a target for radiolabelled small molecules

    PSMA as a target for radiolabelled small molecules gan Matthias Eder, Michael Eisenhut, John W. Babich, Uwe Haberkorn

    Cyhoeddwyd 2013
    Cael y testun llawn Cael y testun llawn
    Editorial
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  7. 7
    [177Lu]Lu-PSMA-617 Salivary Gland Uptake Characterized by Quantitative In Vitro Autoradiography

    [177Lu]Lu-PSMA-617 Salivary Gland Uptake Characterized by Quantitative In Vitro Autoradiography gan Roswitha Tönnesmann, Philipp T. Meyer, Matthias Eder, Ann-Christin Baranski

    Cyhoeddwyd 2019
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  8. 8
    Novel Bispecific PSMA/GRPr Targeting Radioligands with Optimized Pharmacokinetics for Improved PET Imaging of Prostate Cancer

    Novel Bispecific PSMA/GRPr Targeting Radioligands with Optimized Pharmacokinetics for Improved PET Imaging of Prostate Cancer gan Christos Liolios, Martin Schäfer, Uwe Haberkorn, Matthias Eder, Klaus Kopka

    Cyhoeddwyd 2016
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  9. 9
    Dietary Polyphenols in the Prevention of Stroke

    Dietary Polyphenols in the Prevention of Stroke gan Anna Tresserra‐Rimbau, Sara Arranz, Matthias Eder, Anna Vallverdú‐Queralt

    Cyhoeddwyd 2017
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  10. 10
    Specific inhibition of bcr-abl gene expression by small interfering RNA

    Specific inhibition of bcr-abl gene expression by small interfering RNA gan Michaela Scherr, Karin Battmer, Thomas Winkler, Olaf Heidenreich, Arnold Ganser, Matthias Eder

    Cyhoeddwyd 2003
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  11. 11
    Preclinical evaluation of a bispecific low‐molecular heterodimer targeting both PSMA and GRPR for improved PET imaging and therapy of prostate cancer

    Preclinical evaluation of a bispecific low‐molecular heterodimer targeting both PSMA and GRPR for improved PET imaging and therapy of prostate cancer gan Matthias Eder, Martin Schäfer, Ulrike Bauder‐Wüst, Uwe Haberkorn, Michael Eisenhut, Klaus Kopka

    Cyhoeddwyd 2014
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  12. 12
    Activation of the Cannabinoid Receptor Type 1 Decreases Glutamatergic and GABAergic Synaptic Transmission in the Lateral Amygdala of the Mouse

    Activation of the Cannabinoid Receptor Type 1 Decreases Glutamatergic and GABAergic Synaptic Transmission in the Lateral Amygdala of the Mouse gan Shahnaz Christina Azad, Matthias Eder, Giovanni Marsicano, Beat Lutz, W. Zieglgänsberger, Gerhard Rammes

    Cyhoeddwyd 2003
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  13. 13
    PSMA-Targeting Radiopharmaceuticals for Prostate Cancer Therapy: Recent Developments and Future Perspectives

    PSMA-Targeting Radiopharmaceuticals for Prostate Cancer Therapy: Recent Developments and Future Perspectives gan Mohamed El Fakiri, Nicolas M. Geis, Nawal Ayada, Matthias Eder, Ann-Christin Eder

    Cyhoeddwyd 2021
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  14. 14
    Enhanced sensitivity to inhibition of SHP2, STAT5, and Gab2 expression in chronic myeloid leukemia (CML)

    Enhanced sensitivity to inhibition of SHP2, STAT5, and Gab2 expression in chronic myeloid leukemia (CML) gan Michaela Scherr, Anuhar Chaturvedi, Karin Battmer, Iris Dallmann, Beate Schultheis, Arnold Ganser, Matthias Eder

    Cyhoeddwyd 2005
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  15. 15
    Shc phosphorylation in myeloid cells is regulated by granulocyte macrophage colony-stimulating factor, interleukin-3, and steel factor and is constitutively increased by p210BCR/ABL.

    Shc phosphorylation in myeloid cells is regulated by granulocyte macrophage colony-stimulating factor, interleukin-3, and steel factor and is constitutively increased by p210BCR/AB... gan Tetsuya Matsuguchi, Ravi Salgia, Michael Hallek, Matthias Eder, Brian J. Druker, T J Ernst, James D. Griffin

    Cyhoeddwyd 1994
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  16. 16
    Incidence, risk factors and healthcare costs of central line-associated nosocomial bloodstream infections in hematologic and oncologic patients

    Incidence, risk factors and healthcare costs of central line-associated nosocomial bloodstream infections in hematologic and oncologic patients gan Claas Baier, Lena Linke, Matthias Eder, Frank Schwab, Iris F. Chaberny, Ralf‐Peter Vonberg, Ella Ebadi

    Cyhoeddwyd 2020
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  17. 17
    Towards Improving the Efficacy of PSMA-Targeting Radionuclide Therapy for Late-Stage Prostate Cancer—Combination Strategies

    Towards Improving the Efficacy of PSMA-Targeting Radionuclide Therapy for Late-Stage Prostate Cancer—Combination Strategies gan D. Arbuznikova, Matthias Eder, Anca‐Ligia Grosu, Philipp T. Meyer, Christian Gratzke, Constantinos Zamboglou, Ann-Christin Eder

    Cyhoeddwyd 2023
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  18. 18
    A dimerized urea-based inhibitor of the prostate-specific membrane antigen for 68Ga-PET imaging of prostate cancer

    A dimerized urea-based inhibitor of the prostate-specific membrane antigen for 68Ga-PET imaging of prostate cancer gan Martin Schäfer, Ulrike Bauder‐Wüst, Karin Leotta, Frederic Zoller, Walter Mier, Uwe Haberkorn, Michael Eisenhut, Matthias Eder

    Cyhoeddwyd 2012
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  19. 19
    Lentivirus-mediated antagomir expression for specific inhibition of miRNA function

    Lentivirus-mediated antagomir expression for specific inhibition of miRNA function gan Michaela Scherr, Letizia Venturini, Karin Battmer, Michael Schaller-Schoenitz, Daniel Schaefer, Iris Dallmann, Arnold Ganser, Matthias Eder

    Cyhoeddwyd 2007
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  20. 20
    68Ga-PSMA-11 Dynamic PET/CT Imaging in Primary Prostate Cancer

    68Ga-PSMA-11 Dynamic PET/CT Imaging in Primary Prostate Cancer gan Christos Sachpekidis, Klaus Kopka, Matthias Eder, Boris Hadaschik, Martin T. Freitag, Leyun Pan, Uwe Haberkorn, Antonia Dimitrakopoulou‐Strauss

    Cyhoeddwyd 2016
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:

Offerynnau Chwilio: